PSG Equity and Rivean Capital Acquire Corilus

July 4, 2024

PSG Equity has made a strategic investment in Corilus alongside existing investor Rivean Capital, with Rivean reinvesting via a continuation vehicle. Corilus, a Ghent-based provider of cloud-based medical software used by more than 30,000 care providers and with ~450 employees, will use the new capital to accelerate product development (including GenAI capabilities) and pursue organic and inorganic expansion across Europe.

Buyers
PSG Equity, Rivean Capital
Targets
Corilus N.V.
Location
East Flanders, Belgium
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.